DEA Expands Buprenorphine Treatment via Telemedicine
March 12, 2025 | Los Angeles, CA — MedLegalNews.com — The U.S. Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA) have finalized a rule expanding access to buprenorphine treatment via telemedicine. This update allows physicians to prescribe schedule III-V controlled substances, including buprenorphine, for opioid use disorder (OUD) treatment—even through […]
DEA Expands Buprenorphine Treatment via Telemedicine Read Post »










